Mueller, J., Kelly, A., Zhou, Q., Iasonos, A., Long Roche, K., Sonoda, Y., . . . Gardner, G. (2016). Interval cytoreductive surgical outcome following administration of standard versus dose-dense neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer. Gynecologic Oncology, 141, 160. https://doi.org/10.1016/j.ygyno.2016.04.418
Chicago Style (17th ed.) CitationMueller, J.J, et al. "Interval Cytoreductive Surgical Outcome Following Administration of Standard Versus Dose-dense Neoadjuvant Chemotherapy in Patients with Advanced-stage Ovarian Cancer." Gynecologic Oncology 141 (2016): 160. https://doi.org/10.1016/j.ygyno.2016.04.418.
MLA (9th ed.) CitationMueller, J.J, et al. "Interval Cytoreductive Surgical Outcome Following Administration of Standard Versus Dose-dense Neoadjuvant Chemotherapy in Patients with Advanced-stage Ovarian Cancer." Gynecologic Oncology, vol. 141, 2016, p. 160, https://doi.org/10.1016/j.ygyno.2016.04.418.